Top Markets
Coin of the day
Shenzhen Lifotronic Technology Co., Ltd. Shenzhen Lifotronic Technology Co., Ltd.

Shenzhen Lifotronic Technology Co., Ltd.

688389
Rank in Stocks #11597
Established in 2008 and headquartered in Shenzhen, China, Shenzhen Lifotronic... Established in 2008 and headquartered in Shenzhen, China, Shenzhen Lifotronic Technology Co., Ltd. specializes in the design, production, and distribution of a wide range of medical devices throughout China, addressing both diagnostic and therapeutic requirements. Its extensive portfolio includes In Vitro Diagnostic (IVD) products, featuring sophisticated analytical instruments such as HPLC systems for hemoglobin and HbA1c measurements, automated ECL immunoassay analyzers, and hematology analyzers. The company also provides Point-of-Care Testing (POCT) solutions, including immunofluorescence analyzers, alongside molecular diagnostics equipment like automated nucleic acid purification systems and real-time PCR platforms. Additionally, Lifotronic offers rapid test kits for key infectious diseases such as COVID-19, malaria, dengue, and influenza A and B. In the therapeutic sector, the company delivers a diverse array of solutions. Respiratory and ICU products encompass video laryngoscopes, warmer units with disposable blankets, high-flow humidification systems, high-frequency chest wall oscillation devices, and intermittent pneumatic compression pumps. For wound care, offerings include negative pressure wound therapy, ultrasound-assisted wound debridement, and wound healing light therapy. Pain management is addressed through ESWT (Extracorporeal Shockwave Therapy) devices, specifically electromagnetic and extracorporeal shockwave systems. Furthermore, Lifotronic is active in medical and aesthetic laser technologies, providing intensive pulsed light systems, fractional CO2 laser systems, Q-switched Nd:YAG laser systems, and fiber laser hair removal systems.
Share Price
$1.59
Last synced: 2026-08-28
Market Cap
$682.41M
Change (1 day)
-0.27%
Change (1 year)
-19.80%
Country
CN
Trade Shenzhen Lifotronic Technology Co., Ltd. (688389)

Category

P/B ratio for Shenzhen Lifotronic Technology Co., Ltd. (688389)
P/B ratio as of 2026 TTM: 0
According to Shenzhen Lifotronic Technology Co., Ltd. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Shenzhen Lifotronic Technology Co., Ltd. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors